Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 236148, 9 pages
http://dx.doi.org/10.1155/2012/236148
Review Article

HCV-Related Nervous System Disorders

Section of Neuropathology, Department of Neurological, Neuropsychological, Morphological and Motor Sciences, University of Verona, Verona 37134, Italy

Received 23 April 2012; Accepted 26 June 2012

Academic Editor: Domenico Sansonno

Copyright © 2012 Salvatore Monaco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. M. Lauer and B. D. Walker, “Hepatitis C virus infection,” New England Journal of Medicine, vol. 345, no. 1, pp. 41–52, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. I. M. Jacobson, P. Cacoub, L. Dal Maso, S. A. Harrison, and Z. M. Younossi, “Manifestations of chronic hepatitis C virus infection beyond the liver,” Clinical Gastroenterology and Hepatology, vol. 8, no. 12, pp. 1017–1029, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Dammacco, D. Sansonno, C. Piccoli, V. Racanelli, F. P. D'Amore, and G. Lauletta, “The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy,” Seminars in Liver Disease, vol. 20, no. 2, pp. 143–157, 2000. View at Google Scholar · View at Scopus
  4. N. F. Fletcher and J. A. McKeating, “Hepatitis C virus and the brain,” Journal of Viral Hepatitis, vol. 19, no. 5, pp. 301–306, 2012. View at Publisher · View at Google Scholar
  5. D. Sansonno and F. Dammacco, “Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations,” Lancet Infectious Diseases, vol. 5, no. 4, pp. 227–236, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Sargur, P. White, and W. Egner, “Cryoglobulin evaluation: best practice?” Annals of Clinical Biochemistry, vol. 47, no. 1, pp. 8–16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. J. Robbins, A. A. M. Shaheen, and R. P. Myers, “Immunologic complications of the hepatitis C virus,” Current Hepatitis Reports, vol. 6, no. 4, pp. 138–144, 2007. View at Google Scholar · View at Scopus
  8. L. Origgi, M. Vanoli, A. Carbone, M. Grasso, and R. Scorza, “Central nervous system involvement in patients with HCV-related cryoglobulinemia,” American Journal of the Medical Sciences, vol. 315, no. 3, pp. 208–210, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Ramos-Casals, A. Robles, P. Brito-Zerón et al., “Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases,” Seminars in Arthritis and Rheumatism, vol. 36, no. 3, pp. 189–196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. G. W. Petty, J. Duffy, and J. Huston, “Cerebral ischemia in patients with hepatitis c virus infection and mixed cryoglobulinemia,” Mayo Clinic Proceedings, vol. 71, no. 7, pp. 671–678, 1996. View at Google Scholar · View at Scopus
  11. P. Cacoub, A. Sbaï, P. Hausfater, T. Papo, A. Gatel, and J. C. Piette, “Central nervous system involvement in patients with hepatitis C virus infection,” Gastroenterologie Clinique et Biologique, vol. 22, no. 6-7, pp. 631–633, 1998. View at Google Scholar · View at Scopus
  12. M. G. Arena, E. Ferlazzo, D. Bonanno, P. Quattrocchi, and B. Ferlazzo, “Cerebral vasculitis in a patient with HCV-related type II mixed cryoglobulinemia,” Journal of Investigational Allergology and Clinical Immunology, vol. 13, no. 2, pp. 135–136, 2003. View at Google Scholar · View at Scopus
  13. J. G. Heckmann, C. Kayser, D. Heuss, B. Manger, H. E. Blum, and B. Neundörfer, “Neurological manifestations of chronic hepatitis C,” Journal of Neurology, vol. 246, no. 6, pp. 486–491, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. T. M. Dawson and G. Starkebaum, “Isolated central nervous system vasculitis associated with hepatitis C infection,” Journal of Rheumatology, vol. 26, no. 10, pp. 2273–2276, 1999. View at Google Scholar · View at Scopus
  15. S. D. H. Malnick, Y. Abend, E. Evron, and Z. M. Sthoeger, “HCV hepatitis associated with anticardiolipin antibody and a cerebrovascular accident: response to interferon therapy,” Journal of Clinical Gastroenterology, vol. 24, no. 1, pp. 40–42, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. M. H. Lee, H. I. Yang, C. H. Wang et al., “Hepatitis C virus infection and increased risk of cerebrovascular disease,” Stroke, vol. 41, no. 12, pp. 2894–2900, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Serena, R. Biscaro, G. Moretto, and E. Recchia, “Peripheral and central nervous system involvement in essential mixed cryoglobulinemia: a case report,” Clinical Neuropathology, vol. 10, no. 4, pp. 177–180, 1991. View at Google Scholar · View at Scopus
  18. R. Buccoliero, S. Gambelli, F. Sicurelli et al., “Leukoencephalopathy as a rare complication of hepatitis C infection,” Neurological Sciences, vol. 27, no. 5, pp. 360–363, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Casato, D. Saadoun, A. Marchetti et al., “Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests,” Journal of Rheumatology, vol. 32, no. 3, pp. 484–488, 2005. View at Google Scholar · View at Scopus
  20. F. Seifert, T. Struffert, M. Hildebrandt et al., “In vivo detection of hepatitis C virus (HCV) RNA in the brain in a case of encephalitis: evidence for HCV neuroinvasion,” European Journal of Neurology, vol. 15, no. 3, pp. 214–218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Bolay, F. Söylemezoǧlu, G. Nurlu, S. Tuncer, and K. Varli, “PCR detected hepatitis C virus genome in the brain of a case with progressive encephalomyelitis with rigidity,” Clinical Neurology and Neurosurgery, vol. 98, no. 4, pp. 305–308, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Sacconi, L. Salviati, and E. Merelli, “Acute disseminated encephalomyelitis associated with hepatitis C virus infection,” Archives of Neurology, vol. 58, no. 10, pp. 1679–1681, 2001. View at Google Scholar · View at Scopus
  23. T. A. Mestre, J. Correia de Sá, and J. Pimentel, “Multifocal central and peripheral demyelination associated with hepatitis C virus infection [7],” Journal of Neurology, vol. 254, no. 12, pp. 1754–1756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. L. Bezerra, J. A. Harumi, J. S. Morais Shinosaki et al., “Hepatitis C virus: a rare manifestation-Remitting relapsing central and peripheral demyelination,” Neurology India, vol. 59, no. 1, pp. 114–116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. K. M. Aktipi, S. Ravaglia, M. Ceroni et al., “Severe recurrent myelitis in patients with hepatitis C virus infection,” Neurology, vol. 68, no. 6, pp. 468–469, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Zandman-Goddard, Y. Levy, P. Weiss, Y. Shoenfeld, and P. Langevitz, “Transverse myelitis associated with chronic hepatitis C,” Clinical and Experimental Rheumatology, vol. 21, no. 1, pp. 111–113, 2003. View at Google Scholar · View at Scopus
  27. C. H. Nolte, A. S. Endres, and H. Meisel, “Sensory ataxia in myelopathy with chronic hepatitis C virus infection,” Neurology, vol. 59, no. 6, p. 958, 2002. View at Google Scholar · View at Scopus
  28. D. M. De Carli, J. Pannebeker, F. L. Pedro, C. J. P. Haygert, E. Hertz, and M. D. O. Beck, “Transverse myelitis associated to HCV infection,” Brazilian Journal of Infectious Diseases, vol. 13, no. 2, pp. 147–152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. A. K. Grewal, M. B. Lopes, C. L. Berg, A. K. Bennett, V. A. F. Alves, and J. M. Trugman, “Recurrent demyelinating myelitis associated with hepatitis C viral infection,” Journal of the Neurological Sciences, vol. 224, no. 1-2, pp. 101–106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Takahashi-Fujigasaki, S. Takagi, T. Sakamoto, and K. Inoue, “Spinal cord biopsy findings of anti-aquaporin-4 antibody-negative recurrent longitudinal myelitis in a patient with sicca symptoms and hepatitis C viral infection: case Report,” Neuropathology, vol. 29, no. 4, pp. 472–479, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Goh, B. Coughlan, J. Quinn, J. C. O'Keane, and J. Crowe, “Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection,” European Journal of Gastroenterology and Hepatology, vol. 11, no. 8, pp. 833–838, 1999. View at Google Scholar · View at Scopus
  32. D. M. Forton, J. M. Allsop, J. Main, G. R. Foster, H. C. Thomas, and S. D. Taylor-Robinson, “Evidence for a cerebral effect of the hepatitis C virus,” The Lancet, vol. 358, no. 9275, pp. 38–39, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Weissenborn, J. Krause, M. Bokemeyer et al., “Hepatitis C virus infection affects the brain - Evidence from psychometric studies and magnetic resonance spectroscopy,” Journal of Hepatology, vol. 41, no. 5, pp. 845–851, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. M. P. McAndrews, K. Farcnik, P. Carlen et al., “Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors,” Hepatology, vol. 41, no. 4, pp. 801–808, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Bokemeyer, X. Q. Ding, A. Goldbecker et al., “Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy,” Gut, vol. 60, no. 3, pp. 370–377, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Piche, G. Vanbiervliet, F. Cherikh et al., “Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study,” Gut, vol. 54, no. 8, pp. 1169–1173, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. E. A. Jones, “Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy,” The Lancet, vol. 354, no. 9176, p. 397, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Cozzi, A. L. Zignego, R. Carpendo et al., “Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients,” Journal of Viral Hepatitis, vol. 13, no. 6, pp. 402–408, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Weissenborn, J. C. Ennen, M. Bokemeyer et al., “Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment,” Gut, vol. 55, no. 11, pp. 1624–1630, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Heeren, K. Weissenborn, D. Arvanitis et al., “Cerebral glucose utilisation in hepatitis C virus infection-associated encephalopathy,” Journal of Cerebral Blood Flow and Metabolism, vol. 31, no. 11, pp. 2199–2208, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. M. G. Carta, J. Angst, M. F. Moro et al., “Association of chronic hepatitis C with recurrent brief depression,” Journal of Affective Disorders. In press.
  42. K. Weissenborn, A. B. Tryc, M. Heeren et al., “Hepatitis C virus infection and the brain,” Metabolic Brain Disease, vol. 24, no. 1, pp. 197–210, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. R. J. Fontana, Z. Kronfol, K. L. Lindsay et al., “Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C,” American Journal of Gastroenterology, vol. 103, no. 11, pp. 2766–2775, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Córdoba, M. Flavià, C. Jacas et al., “Quality of life and cognitive function in hepatitis C at different stages of liver disease,” Journal of Hepatology, vol. 39, no. 2, pp. 231–238, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Soogoor, H. S. Lynn, S. M. Donfield, E. Gomperts, T. S. Bell, and E. S. Daar, “Hepatitis C virus infection and neurocognitive function,” Neurology, vol. 67, no. 8, pp. 1482–1485, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. D. M. Forton, H. C. Thomas, C. A. Murphy et al., “Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease,” Hepatology, vol. 35, no. 2, pp. 433–439, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. R. J. Fontana, L. A. Bieliauskas, C. Back-Madruga et al., “Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial,” Journal of Hepatology, vol. 43, no. 4, pp. 614–622, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Lowry, B. Coughlan, O. McCarthy, and J. Crowe, “Investigating health-related quality of life, mood and neuropsychological test performance in a homogeneous cohort of Irish female hepatitis C patients,” Journal of Viral Hepatitis, vol. 17, no. 5, pp. 352–359, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Kramer, E. Bauer, G. Funk et al., “Subclinical impairment of brain function in chronic hepatitis C infection,” Journal of Hepatology, vol. 37, no. 3, pp. 349–354, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. D. M. Forton, P. Karayiannis, N. Mahmud, S. D. Taylor-Robinson, and H. C. Thomas, “Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants,” Journal of Virology, vol. 78, no. 10, pp. 5170–5183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Murray, S. L. Fishman, E. Ryan et al., “Clinicopathologic correlates of hepatitis C virus in brain: a pilot study,” Journal of NeuroVirology, vol. 14, no. 1, pp. 17–27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. S. L. Fishman, J. M. Murray, F. J. Eng, J. L. Walewski, S. Morgello, and A. D. Branch, “Molecular and bioinformatic evidence of hepatitis C virus evolution in brain,” Journal of Infectious Diseases, vol. 197, no. 4, pp. 597–607, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Laskus, M. Radkowski, A. Bednarska et al., “Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid,” Journal of Virology, vol. 76, no. 19, pp. 10064–10068, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Radkowski, J. Wilkinson, M. Nowicki et al., “Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication,” Journal of Virology, vol. 76, no. 2, pp. 600–608, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Letendre, A. D. Paulino, E. Rockenstein et al., “Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV,” Journal of Infectious Diseases, vol. 196, no. 3, pp. 361–370, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. N. F. Fletcher, G. K. Wilson, J. Murray et al., “Hepatitis C virus infects the endothelial cells of the blood-brain barrier,” Gastroenterology, vol. 142, no. 3, pp. 634–643, 2012. View at Publisher · View at Google Scholar
  57. B. Bonetti, F. Invernizzi, N. Rizzuto et al., “T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy,” Journal of Neuroimmunology, vol. 73, no. 1-2, pp. 145–154, 1997. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Vital, A. Vital, M. H. Canron et al., “Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases,” Journal of the Peripheral Nervous System, vol. 11, no. 1, pp. 20–29, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. B. Bonetti, S. Monaco, C. Giannini, S. Ferrari, G. L. Zanusso, and N. Rizzuto, “Human peripheral nerve macrophages in normal and pathological conditions,” Journal of the Neurological Sciences, vol. 118, no. 2, pp. 158–168, 1993. View at Publisher · View at Google Scholar · View at Scopus
  60. B. Bonetti, M. Scardoni, N. Rizzuto, A. Scarpa, and S. Monaco, “Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia,” Virchows Archiv, vol. 434, no. 6, pp. 533–535, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. L. De Martino, S. Sampaolo, C. Tucci et al., “Viral RNA in nerve tissues of patients with hepatitis C infection and peripheral neuropathy,” Muscle and Nerve, vol. 27, no. 1, pp. 102–104, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. F. J. Authier, G. Bassez, C. Payan et al., “Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy,” Neurology, vol. 60, no. 5, pp. 808–812, 2003. View at Google Scholar · View at Scopus
  63. S. Ferrari, S. Vento, S. Monaco et al., “Human immunodeficiency virus-associated peripheral neuropathies,” Mayo Clinic Proceedings, vol. 81, no. 2, pp. 213–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. F. Gemignani, F. Brindani, S. Alfieri et al., “Clinical spectrum of cryoglobulinaemic neuropathy,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 10, pp. 1410–1414, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. M. S. Yoon, M. Obermann, C. Dockweiler et al., “Sensory neuropathy in patients with cryoglobulin negative hepatitis-C infection,” Journal of Neurology, vol. 258, no. 1, pp. 80–88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Bant, B. Hurowitz, N. Hassan, D. U. Van Thiel, and A. Nadir, “Complex regional pain syndrome (Reflex sympathetic dystrophy) in a patient with essential mixed cryoglobulinemia and chronic hepatitis C,” Journal of the Pakistan Medical Association, vol. 57, no. 2, pp. 96–98, 2007. View at Google Scholar · View at Scopus
  67. J. Costa, C. Resende, and M. De Carvalho, “Motor-axonal polyneuropathy associated with hepatitis C virus,” European Journal of Neurology, vol. 10, no. 2, pp. 183–185, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Ammendola, S. Sampaolo, S. Migliaresi et al., “Autonomic neuropathy in mixed cryoglobulinemia,” Journal of Neurology, vol. 254, no. 2, pp. 215–219, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. C. F. Lippa, D. A. Chad, and T. W. Smith, “Neuropathy associated with cryoglobulinemia,” Muscle and Nerve, vol. 9, no. 7, pp. 626–631, 1986. View at Google Scholar · View at Scopus
  70. R. L. Chin, H. W. Sander, T. H. Brannagan, E. De Sousa, and N. Latov, “Demyelinating neuropathy in patients with hepatitis C virus infection,” Journal of Clinical Neuromuscular Disease, vol. 11, no. 4, pp. 209–212, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. C. M. Caporale, M. Capasso, M. Ragno, A. Di Muzio, and A. Uncini, “Lewis-Sumner syndrome in hepatitis C virus infection: a possible pathogenetic association with therapeutic problems,” Muscle and Nerve, vol. 34, no. 1, pp. 116–121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Boukhris, L. Magy, U. Senga-Mokono, V. Loustaud-Ratti, and J. M. Vallat, “Polyneuropathy with demyelinating features in mixed cryoglobulinemia with hepatitis C virus infection,” European Journal of Neurology, vol. 13, no. 9, pp. 937–941, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Zoccolella, L. Serlenga, A. Amati et al., “A case of vacuolar myopathy during the course of chronic hepatitis C.,” Functional Neurology, vol. 21, no. 3, pp. 167–169, 2006. View at Google Scholar · View at Scopus
  74. J. I. Satoh, Y. I. Eguchi, T. Narukiyo et al., “Necrotizing myopathy in a patient with chronic hepatitis C virus infection: a case peport and a review of the literature,” Internal Medicine, vol. 39, no. 2, pp. 176–181, 2000. View at Google Scholar · View at Scopus
  75. P. Cortelli, J. Mandrioli, M. Zeviani et al., “Mitochondrial complex III deficiency in a case of HCV related noninflammatory myopathy [4],” Journal of Neurology, vol. 254, no. 10, pp. 1450–1452, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. N. Zhu, A. Khoshnan, R. Schneider et al., “Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis,” Journal of Virology, vol. 72, no. 5, pp. 3691–3697, 1998. View at Google Scholar · View at Scopus
  77. L. Alric, J. Partensky, D. Reynaud, O. Rauzy, and M. Duffaut, “Association between polymyositis and hepatitis C virus infection: treatment-related difficulties,” Revue de Medecine Interne, vol. 21, no. 6, pp. 542–546, 2000. View at Publisher · View at Google Scholar · View at Scopus
  78. Y. Horsmans and A. P. Geubel, “Symptomatic myopathy in hepatitis C infection without interferon therapy,” The Lancet, vol. 345, no. 8959, p. 1236, 1995. View at Google Scholar · View at Scopus
  79. Y. Aisa, H. Yokomori, K. Kashiwagi et al., “Polymyositis, pulmonary fibrosis and malignant lymphoma associated with hepatitis C virus infection,” Internal Medicine, vol. 40, no. 11, pp. 1109–1112, 2001. View at Google Scholar · View at Scopus
  80. Y. Ueno, K. Kondo, N. Kidokoro, R. Kobashi, K. Kanaji, and T. Matsumura, “Hepatitis C infection and polymyositis,” The Lancet, vol. 346, no. 8970, pp. 319–320, 1995. View at Google Scholar · View at Scopus
  81. H. Ito, H. Ito, M. Nagano, S. Nakano, Y. Shigeyoshi, and H. Kusaka, “In situ identification of hepatitis C virus RNA in muscle,” Neurology, vol. 64, no. 6, pp. 1073–1075, 2005. View at Google Scholar · View at Scopus
  82. M. Villanova, C. Caudai, P. Sabatelli et al., “Hepatitis C virus infection and myositis: a polymerase chain reaction study,” Acta Neuropathologica, vol. 99, no. 3, pp. 271–276, 2000. View at Google Scholar · View at Scopus
  83. K. M. Kee, J. H. Wang, C. M. Lee, C. S. Changchien, and H. L. Eng, “Chronic hepatitis C virus infection associated with dermatomyositis and hepatocellular carcinoma,” Chang Gung Medical Journal, vol. 27, no. 11, pp. 834–839, 2004. View at Google Scholar · View at Scopus
  84. S. Kase, G. Shiota, Y. Fujii et al., “Inclusion body myositis associated with hepatitis C virus infection,” Liver, vol. 21, no. 5, pp. 357–360, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. Y. Tsuruta, T. Yamada, T. Yoshimura et al., “Inclusion body myositis associated with hepatitis C virus infection,” Fukuoka Igaku Zasshi, vol. 92, no. 11, pp. 370–376, 2001. View at Google Scholar · View at Scopus